Jeff Yass’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,300
| Closed | -$261K | – | 13697 |
|
|
2026
Q1 | $261K | Hold |
1,300
| – | – | ﹤0.01% | 11170 |
|
|
2025
Q4 | $268K | Buy |
+1,300
| New | +$260K | ﹤0.01% | 10218 |
|
|
2022
Q4 | – | Sell |
-1,700
| Closed | -$224K | – | 12770 |
|
|
2022
Q3 | $224K | Buy |
+1,700
| New | +$239K | ﹤0.01% | 10544 |
|
|
2021
Q3 | – | Sell |
-6,700
| Closed | -$1.16M | – | 12942 |
|
|
2021
Q2 | $1.16M | Hold |
6,700
| – | – | ﹤0.01% | 7357 |
|
|
2021
Q1 | $1.07M | Buy |
+6,700
| New | +$1.15M | ﹤0.01% | 7545 |
|
|
2020
Q2 | – | Sell |
-2,300
| Closed | -$302K | – | 10323 |
|
|
2020
Q1 | $302K | Sell |
2,300
-3,300
| -59% | -$470K | ﹤0.01% | 7963 |
|
|
2019
Q4 | $833K | Buy |
5,600
+1,800
| +47% | +$247K | ﹤0.01% | 5884 |
|
|
2019
Q3 | $470K | Sell |
3,800
-2,200
| -37% | -$293K | ﹤0.01% | 7430 |
|
|
2019
Q2 | $845K | Buy |
6,000
+1,600
| +36% | +$221K | ﹤0.01% | 6067 |
|
|
2019
Q1 | $664K | Buy |
4,400
+2,000
| +83% | +$288K | ﹤0.01% | 5766 |
|
|
2018
Q4 | $298K | Sell |
2,400
-6,300
| -72% | -$861K | ﹤0.01% | 7013 |
|
|
2018
Q3 | $1.38M | Buy |
8,700
+6,500
| +295% | +$984K | ﹤0.01% | 4639 |
|
|
2018
Q2 | $308K | Sell |
2,200
-600
| -21% | -$82.4K | ﹤0.01% | 7785 |
|
|
2018
Q1 | $372K | Sell |
2,800
-2,800
| -50% | -$382K | ﹤0.01% | 7232 |
|
|
2017
Q4 | $698K | Sell |
5,600
-400
| -7% | -$49.4K | ﹤0.01% | 5950 |
|
|
2017
Q3 | $744K | Buy |
+6,000
| New | +$710K | ﹤0.01% | 5815 |
|
|
2017
Q2 | – | Sell |
-3,600
| Closed | -$379K | – | 9348 |
|
|
2017
Q1 | $379K | Buy |
3,600
+200
| +6% | +$20K | ﹤0.01% | 6988 |
|
|
2016
Q4 | $309K | Sell |
3,400
-10,200
| -75% | -$955K | ﹤0.01% | 7925 |
|
|
2016
Q3 | $1.36M | Buy |
13,600
+10,600
| +353% | +$1.04M | ﹤0.01% | 4232 |
|
|
2016
Q2 | $268K | Sell |
3,000
-6,700
| -69% | -$615K | ﹤0.01% | 7139 |
|
|
2016
Q1 | $849K | Sell |
9,700
-1,600
| -14% | -$141K | ﹤0.01% | 5414 |
|
|
2015
Q4 | $1.28M | Sell |
11,300
-10,600
| -48% | -$1.14M | ﹤0.01% | 4929 |
|
|
2015
Q3 | $2.22M | Buy |
21,900
+5,700
| +35% | +$678K | ﹤0.01% | 4073 |
|
|
2015
Q2 | $2.01M | Sell |
16,200
-4,300
| -21% | -$519K | ﹤0.01% | 4709 |
|
|
2015
Q1 | $2.42M | Buy |
20,500
+15,000
| +273% | +$1.7M | ﹤0.01% | 3940 |
|
|
2014
Q4 | $561K | Buy |
+5,500
| New | +$537K | ﹤0.01% | 6999 |
|
|
2014
Q3 | – | Sell |
-19,400
| Closed | -$1.6M | – | 9548 |
|
|
2014
Q2 | $1.6M | Sell |
19,400
-76,500
| -80% | -$5.85M | ﹤0.01% | 5087 |
|
|
2014
Q1 | $7.36M | Buy |
95,900
+83,700
| +686% | +$6.53M | ﹤0.01% | 2377 |
|
|
2013
Q4 | $844K | Sell |
12,200
-9,000
| -42% | -$590K | ﹤0.01% | 5791 |
|
|
2013
Q3 | $1.37M | Sell |
21,200
-1,300
| -6% | -$82.2K | ﹤0.01% | 4759 |
|
|
2013
Q2 | $1.31M | Buy |
+22,500
| New | +$1.29M | ﹤0.01% | 4563 |
|
Other funds holding FBT
BFG
Jeff Yass's FBT Position: Q2 2026 in Review
Jeff Yass reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 69% in Q2 2026, selling an estimated $4.77M and leaving 10,048 shares worth $2.49M. The position accounts for ﹤0.01% of the portfolio, ranked #5987.
Jeff Yass first reported a position in FBT in Q2 2013 and has held it in 47 quarters since. The position peaked at $25.6M in Q2 2013. 338 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- Jeff Yass held 10,048 shares of First Trust NYSE Arca Biotechnology Index Fund worth $2.49M as of Q2 2026.
- Jeff Yass sold 22,164 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $4.77M.
- First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5987 holding.
- Jeff Yass first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 47 quarters since.
- Jeff Yass's First Trust NYSE Arca Biotechnology Index Fund position peaked at $25.6M in Q2 2013.
- 338 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.